## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy (DR) grading that generates lesion proposals internally without requiring external annotations. The method introduces two modules: GALP, which derives grade-conditioned evidence maps from auxiliary classifiers and selects top-K high-evidence regions as lesion proposals, and LGRF, which uses cross-view lesion proposals to guide fusion via gated mixture-of-experts and top-K weighted cross-view attention. Experiments on two multi-view DR datasets show that the method matches or surpasses strong baselines, including externally informed methods, while reducing annotation dependency.

## Strengths

- **Well-motivated problem**: Reducing reliance on expensive external annotations for DR grading is practically important, and the paper clearly articulates the limitations of both purely end-to-end and externally informed approaches.
- **Novel technical design**: The combination of self-derived lesion proposals (via CAM from auxiliary classifiers) with cross-view expert routing and top-K weighted attention is a creative and coherent integration of existing ideas.
- **Comprehensive evaluation**: Experiments on two multi-view datasets (MFIDDR and DRTiD) with comparisons to a wide range of baselines, including both end-to-end and externally informed methods, demonstrate the effectiveness of the approach.
- **Ablation and hyperparameter analysis**: The paper systematically ablates the key components (GALP, LGRF, experts) and studies the sensitivity of important hyperparameters (retention ratio, number of experts), providing insight into design choices.

## Weaknesses

### Major

- **Lack of statistical significance**: The reported improvements over strong baselines (e.g., 83.9% vs. 84.2% for WGLIN on MFIDDR) are small, and the paper does not provide confidence intervals, p-values, or multiple-run statistics. Without such analysis, it is unclear whether the gains are meaningful or due to random variation.
- **Potential unfair backbone comparison**: The paper uses Swin-B as the backbone, while many compared baselines (e.g., MVCINN, MVCNN) use different architectures (custom CNNs, ResNet, VGG). The performance gap may partly reflect backbone strength rather than the proposed modules. The paper should either re-implement baselines with the same backbone or explicitly discuss this confound.
- **No qualitative validation of lesion proposals**: The core claim is that GALP generates meaningful lesion proposals that act as surrogates for expert cues. However, the paper provides no visual examples showing that the selected regions actually correspond to lesions (e.g., microaneurysms, hemorrhages). Without such evidence, the mechanism remains a black box.
- **Limited justification for design choices**: Several architectural decisions are not well motivated: (1) why fuse only with the adjacent view (cyclic) rather than all other views? (2) why use a fixed retention ratio α=50% across all stages? (3) why use focal loss for auxiliary classification? The hyperparameter analysis only varies one parameter at a time and does not explore interactions.

### Minor

- **No efficiency analysis**: The paper does not report inference time, FLOPs, or parameter count. For clinical deployment, computational cost is important, especially with the added MoE and cross-attention modules.
- **CAM limitations not discussed**: Class activation maps are known to be noisy and may highlight spurious correlations (e.g., image artifacts) rather than true lesions. The paper should acknowledge this limitation and discuss potential failure cases.
- **Lesion annotations are model-generated**: On MFIDDR, the "with lesion" variant uses segmentation masks produced by an external model, not human annotations. This weakens the claim about reducing annotation burden, as the model still relies on a separately trained segmenter.

## Nice-to-Haves

- Provide visualizations of the generated lesion proposals (GEMs and selected regions) for different grades to qualitatively validate that they correspond to clinically meaningful structures.
- Report results with multiple random seeds and include confidence intervals or standard deviations.
- Compare with a stronger end-to-end baseline that uses the same Swin-B backbone but without the proposed modules, to isolate the contribution of GALP and LGRF.
- Analyze the computational overhead (FLOPs, inference time) relative to the baseline.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

- Add a statistical significance analysis (e.g., bootstrapped confidence intervals or paired t-tests) for the main results to support the claim of improvement.
- Include qualitative examples of the grade-conditioned evidence maps and the top-K selected regions, with overlay on original fundus images, to demonstrate that proposals correspond to lesions.
- Re-implement the strongest end-to-end baselines (e.g., MVCINN, ETMC) with the same Swin-B backbone to ensure fair comparison, or at least discuss the backbone discrepancy as a limitation.
- Explore fusing with all other views instead of only the adjacent view, and report the impact on performance.

## Score and Decision

MY FINAL SCORE: <score>6</score>
MY FINAL DECISION: <decision>Accept</decision>